All news articles for May 2017

Integrated Development Associates Co. Ltd. (IDA) specializes in integrating Japan and Asia into global drug development. (Image: iStock/Kritchanut)

Chiltern acquires Japanese CRO

By Melissa Fassbender

Chiltern has acquired Integrated Development Associates Co. Ltd. (IDA), a Japenese contract research organization (CRO) with offices in Japan, Korea, and Southeast Asia.

Outsourcing-Pharma's Hiring and Firing Roundup May '17

People on the move

Outsourcing-Pharma's Hiring and Firing Roundup May '17

By Melissa Fassbender

This month’s roundup includes new executive leadership teams, hires on both sides of the Atlantic for CRO Smithers Viscient, a new VP and medical director at Clinipace, among others.

ICH GCP E6(R2) guidelines outline a risk-based approach to clinical trial monitoring. (Image: iStock/liuzishan)

CROS NT extends Medidata partnership

By Melissa Fassbender

The extended partnership provides CROS NT customers access to Medidata’s electronic data capture (EDC) solution as well as its randomization and trial supply management system (RTSM).

iStock/ia_64

Eye drops to replace painful injections in AMD patients

By Flora Southey

The University of Birmingham has developed a cell-penetrating peptide it claims could be used to make eye drop versions of age-related macular degeneration drugs currently delivered by injection.

The First-in-Human trial demonstrated that the novel challenge agent had high attack rates of up to 100%. (Image: iStock/bodym)

SGS completes Ph I trial of new influenza virus

By Melissa Fassbender

SGS has completed a Phase I clinical trial of a new influenza virus strain in healthy volunteers and has increased capacity at its Mississauga, Canada-based laboratory.

CRO turnover increased from 20.1% in 2015 to 22% last year. (Image: iStock/PhotoProdra)

Report: CRO turnover creates loss of continuity

By Melissa Fassbender

Contract research organizations (CROs) continue to see high instances of turnover, which can lead to delayed timelines and sponsor scrutiny, according to a recent survey.

iStock/designer491

IFPMA launches Alliance to track drug firms' progress in the fight against ‘superbugs'.

Charity urges drug industry to consider supplier role in “superbug” spread

By Flora Southey

Drug manufacturers, retail pharmacies and regulators have a role to play in curbing antimicrobial resistance say campaigners urging industry to ensure their API suppliers are not part of the problem.

(Image: iStock/tadamichi)

CPhI North America

Cambrex invests $2.4m at former PharmaCore site

By Melissa Fassbender

Cambrex Corporation is installing a fourth reactor suite at its High Point, NC-based facility as it continues to grow with its customers in the market, says company VP at CPhI North America.

(Image: iStock/sudok1)

LabCorp completes acquisition of PAML

By Melissa Fassbender

LabCorp has completed its acquisition of Pathology Associates Medical Laboratories (PAML), which will be integrated into its national network of regional and specialty laboratories.